SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Flávio Guimarães da Fonseca, Luis Adan Flores, Immune responses to acute orthopoxvirus infections: what lessons can be learned?, Future Virology, 2014, 9, 8, 699

    CrossRef

  2. 2
    Erica Goodhew, Sheri Maria G Morgan, Andrew J Switzer, Beatriz Munoz, Laura Dize, Charlotte Gaydos, Harran Mkocha, Sheila K West, Ryan E Wiegand, Patrick J Lammie, Diana L Martin, Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration, BMC Infectious Diseases, 2014, 14, 1, 216

    CrossRef

  3. 3
    Daniela Carla Medeiros-Silva, Eduardo Augusto dos Santos Moreira-Silva, Juliana de Assis Silva Gomes, Flávio Guimarães da Fonseca, Rodrigo Correa-Oliveira, CD4 and CD8 T cells participate in the immune memory response against Vaccinia virus after a previous natural infection, Results in Immunology, 2013, 3, 104

    CrossRef

  4. 4
    Daniel Bourquain, Andreas Nitsche, Cowpox virus but not Vaccinia virus induces secretion of CXCL1, IL-8 and IL-6 and chemotaxis of monocytes in vitro, Virus Research, 2013, 171, 1, 161

    CrossRef

  5. 5
    R. Sealy, R. J. Webby, J. C. Crumpton, J. L. Hurwitz, Differential localization and function of antibody-forming cells responsive to inactivated or live-attenuated influenza virus vaccines, International Immunology, 2013, 25, 3, 183

    CrossRef

  6. 6
    Youn Soo Choi, Jessica A Yang, Shane Crotty, Dynamic regulation of Bcl6 in follicular helper CD4 T (Tfh) cells, Current Opinion in Immunology, 2013, 25, 3, 366

    CrossRef

  7. 7
    Matt A. Burchill, Beth A. Tamburini, Nathan D. Pennock, Jason T. White, Jonathan S. Kurche, Ross M. Kedl, T cell vaccinology: Exploring the known unknowns, Vaccine, 2013, 31, 2, 297

    CrossRef

  8. 8
    Simon J. Draper, Matthew G. Cottingham, Sarah C. Gilbert, Utilizing poxviral vectored vaccines for antibody induction—Progress and prospects, Vaccine, 2013, 31, 39, 4223

    CrossRef

  9. 9
    Richard B. Kennedy, J. Michael Lane, Donald A. Henderson, Gregory A. Poland, Vaccines, 2013,

    CrossRef

  10. 10
    Yuan Zhao, Michael Croft, Dispensable role for 4-1BB and 4-1BBL in development of vaccinia virus-specific CD8 T cells, Immunology Letters, 2012, 141, 2, 220

    CrossRef

  11. 11
    Juliana Assis Silva Gomes, Fernanda Fortes de Araújo, Giliane de Souza Trindade, Bárbara Resende Quinan, Betânia Paiva Drumond, Jaqueline Maria Siqueira Ferreira, Bruno Eduardo Fernandes Mota, Maurício Lacerda Nogueira, Erna Geessien Kroon, Jônatas Santos Abrahão, Rodrigo Côrrea-Oliveira, Flávio Guimarães da Fonseca, Immune Modulation in PrimaryVaccinia virusZoonotic Human Infections, Clinical and Developmental Immunology, 2012, 2012, 1

    CrossRef

  12. 12
    Gary Hermanson, Sookhee Chun, Jiin Felgner, Xiaolin Tan, Jozelyn Pablo, Rie Nakajima-Sasaki, Douglas M. Molina, Philip L. Felgner, Xiaowu Liang, D. Huw Davies, Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax® using proteome microarrays and development of recombinant protein ELISAs, Vaccine, 2012, 30, 3, 614

    CrossRef

  13. 13
    Elly van Riet, Akira Ainai, Tadaki Suzuki, Hideki Hasegawa, Mucosal IgA responses in influenza virus infections; thoughts for vaccine design, Vaccine, 2012, 30, 40, 5893

    CrossRef

  14. 14
    Bart G. Jones, Robert E. Sealy, Rajeev Rudraraju, Vicki L. Traina-Dorge, Brad Finneyfrock, Anthony Cook, Toru Takimoto, Allen Portner, Julia L. Hurwitz, Sendai virus-based RSV vaccine protects African green monkeys from RSV infection, Vaccine, 2012, 30, 5, 959

    CrossRef

  15. 15
    Jeffrey W. Froude, Bradley G. Stiles, Thibaut Pelat, Philippe Thullier, Antibodies for biodefense, mAbs, 2011, 3, 6, 517

    CrossRef

  16. 16
    Pedro Aide, Carlota Dobaño, Jahit Sacarlal, John J. Aponte, Inácio Mandomando, Caterina Guinovart, Quique Bassat, Montse Renom, Laura Puyol, Eusebio Macete, Esperanza Herreros, Amanda Leach, Marie-Claude Dubois, Marie-Ange Demoitie, Marc Lievens, Johan Vekemans, Christian Loucq, W. Ripley Ballou, Joe Cohen, Pedro L. Alonso, Four year immunogenicity of the RTS,S/AS02A malaria vaccine in Mozambican children during a phase IIb trial, Vaccine, 2011, 29, 35, 6059

    CrossRef

  17. 17
    Rafi Ahmed, Rama S Akondy, Insights into human CD8+ T-cell memory using the yellow fever and smallpox vaccines, Immunology and Cell Biology, 2011, 89, 3, 340

    CrossRef

  18. 18
    Bin Lu, Wenbo Yu, Xiaoxing Huang, Haibo Wang, Li Liu, Zhiwei Chen, Mucosal Immunization Induces a Higher Level of Lasting Neutralizing Antibody Response in Mice by a Replication-Competent Smallpox Vaccine: Vaccinia Tiantan Strain, Journal of Biomedicine and Biotechnology, 2011, 2011, 1

    CrossRef

  19. 19
    John Goulding, Vikas Tahiliani, Shahram Salek-Ardakani, OX40:OX40L axis: emerging targets for improving poxvirus-based CD8+ T-cell vaccines against respiratory viruses, Immunological Reviews, 2011, 244, 1
  20. 20
    Rajeev Rudraraju, Sherri Surman, Bart Jones, Robert Sealy, David L. Woodland, Julia L. Hurwitz, Phenotypes and functions of persistent Sendai virus-induced antibody forming cells and CD8+ T cells in diffuse nasal-associated lymphoid tissue typify lymphocyte responses of the gut, Virology, 2011, 410, 2, 429

    CrossRef

  21. 21
    Julia L Hurwitz, Respiratory syncytial virus vaccine development, Expert Review of Vaccines, 2011, 10, 10, 1415

    CrossRef

  22. 22
    Tatiana Mareeva, Celestine Wanjalla, Matthias J. Schnell, Yuri Sykulev, A novel composite immunotoxin that suppresses rabies virus production by the infected cells, Journal of Immunological Methods, 2010, 353, 1-2, 78

    CrossRef

  23. 23
    Harini Chandra, Sanjeeva Srivastava, Cell-free synthesis-based protein microarrays and their applications, PROTEOMICS, 2010, 10, 4
  24. 24
    Matthew P. Bernard, Simona Bancos, Timothy J. Chapman, Elizabeth P. Ryan, John J. Treanor, Robert C. Rose, David J. Topham, Richard P. Phipps, Chronic inhibition of cyclooxygenase-2 attenuates antibody responses against vaccinia infection, Vaccine, 2010, 28, 5, 1363

    CrossRef

  25. 25
    Helen E. Baxendale, Marina Johnson, Sheila M. Keating, Lindsey Ashton, Polly Burbidge, Sarah Woodgate, Jo Southern, Elizabeth Miller, David Goldblatt, Circulating pneumococcal specific plasma and memory B cells in the elderly two years after pneumococcal conjugate versus polysaccharide vaccination, Vaccine, 2010, 28, 42, 6915

    CrossRef

  26. 26
    Bénédicte Puissant-Lubrano, Philippe Bossi, Frederick Gay, Jean-Marc Crance, Olivia Bonduelle, Daniel Garin, François Bricaire, Brigitte Autran, Behazine Combadière, Control of vaccinia virus skin lesions by long-term-maintained IFN-γ+TNF-α+ effector/memory CD4+ lymphocytes in humans, Journal of Clinical Investigation, 2010, 120, 5, 1636

    CrossRef

  27. 27
    D. W. Grosenbach, A. Berhanu, D. S. King, S. Mosier, K. F. Jones, R. A. Jordan, T. C. Bolken, D. E. Hruby, Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient mice, Proceedings of the National Academy of Sciences, 2010, 107, 2, 838

    CrossRef

  28. 28
    Katrina L Randall, Generating humoral immune memory following infection or vaccination, Expert Review of Vaccines, 2010, 9, 9, 1083

    CrossRef

  29. 29
    Scott A. Brown, Sherri L. Surman, Robert Sealy, Bart G. Jones, Karen S. Slobod, Kristen Branum, Timothy D. Lockey, Nanna Howlett, Pamela Freiden, Patricia Flynn, Julia L. Hurwitz, Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials, Viruses, 2010, 2, 2, 435

    CrossRef

  30. 30
    Paula Ordonhez Rigato, Milton Maciel, Adriana Letícia Goldoni, Orlando Piubelli, Cyro Alves de Brito, Ana Elisa Fusaro, Liciana Xavier Eurico de Alencar, Thomas August, Ernesto Torres Azevedo Marques, Alberto José da Silva Duarte, Maria Notomi Sato, Immunization of neonatal mice with LAMP/p55 HIV gag DNA elicits robust immune responses that last to adulthood, Virology, 2010, 406, 1, 37

    CrossRef

  31. 31
    Aklile Berhanu, David S. King, Stacie Mosier, Robert Jordan, Kevin F. Jones, Dennis E. Hruby, Douglas W. Grosenbach, Impact of ST-246® on ACAM2000™ smallpox vaccine reactogenicity, immunogenicity, and protective efficacy in immunodeficient mice, Vaccine, 2010, 29, 2, 289

    CrossRef

  32. 32
    MR Olson, BE Russ, PC Doherty, SJ Turner, J Stambas, Influenza A virus-specific CD8+T-cell responses: from induction to function, Future Virology, 2010, 5, 2, 175

    CrossRef

  33. 33
    Rafal J. Zielinski, Jeremy V. Smedley, Pin-Yu Perera, Peter M. Silvera, Thomas A. Waldmann, Jacek Capala, Liyanage P. Perera, Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys, Vaccine, 2010, 28, 43, 7081

    CrossRef

  34. 34
    Z S Guo, V Parimi, M E O'Malley, P Thirunavukarasu, M Sathaiah, F Austin, D L Bartlett, The combination of immunosuppression and carrier cells significantly enhances the efficacy of oncolytic poxvirus in the pre-immunized host, Gene Therapy, 2010, 17, 12, 1465

    CrossRef

  35. 35
    O. Kirak, E.-M. Frickel, G. M. Grotenbreg, H. Suh, R. Jaenisch, H. L. Ploegh, Transnuclear Mice with Predefined T Cell Receptor Specificities Against Toxoplasma gondii Obtained via SCNT, Science, 2010, 328, 5975, 243

    CrossRef

  36. 36
    Magdalini Moutaftsi, David C Tscharke, Kerrie Vaughan, David M Koelle, Lawrence Stern, Mauricio Calvo-Calle, Francis Ennis, Masanori Terajima, Gerd Sutter, Shane Crotty, Ingo Drexler, Genoveffa Franchini, Jon W Yewdell, Steven R Head, Janice Blum, Bjoern Peters, Alex Sette, Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens, Future Microbiology, 2010, 5, 2, 221

    CrossRef

  37. 37
    Stacie N. Woolard, Uday Kumaraguru, Viral Vaccines and CTL Response, Journal of Biomedicine and Biotechnology, 2010, 2010, 1

    CrossRef

  38. 38
    Megan K.L. MacLeod, Eric T. Clambey, John W. Kappler, Philippa Marrack, CD4 memory T cells: What are they and what can they do?, Seminars in Immunology, 2009, 21, 2, 53

    CrossRef

  39. You have free access to this content39
    Paul J. Maglione, John Chan, How B cells shape the immune response against Mycobacterium tuberculosis, European Journal of Immunology, 2009, 39, 3
  40. 40
    Nabil Ahmed, Stephen Gottschalk, How to design effective vaccines: lessons from an old success story, Expert Review of Vaccines, 2009, 8, 5, 543

    CrossRef

  41. 41
    Jens Wrammert, Joe Miller, Rama Akondy, Rafi Ahmed, Human Immune Memory to Yellow Fever and Smallpox Vaccination, Journal of Clinical Immunology, 2009, 29, 2, 151

    CrossRef

  42. 42
    Bénédicte Puissant-Lubrano, Béhazine Combadière, Darragh Duffy, Norma Wincker, Marie-Joelle Frachette, Hocine Ait-Mohand, Bernard Verrier, Christine Katlama, Brigitte Autran, Influence of antigen exposure on the loss of long-term memory to childhood vaccines in HIV-infected patients, Vaccine, 2009, 27, 27, 3576

    CrossRef

  43. 43
    Y. Kawakami, Y. Tomimori, K. Yumoto, S. Hasegawa, T. Ando, Y. Tagaya, S. Crotty, T. Kawakami, Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum, Journal of Experimental Medicine, 2009, 206, 6, 1219

    CrossRef

  44. 44
    A.M. Buisman, C.G.H. de Rond, K. Öztürk, H.I. ten Hulscher, R.S. van Binnendijk, Long-term presence of memory B-cells specific for different vaccine components, Vaccine, 2009, 28, 1, 179

    CrossRef

  45. 45
    Adam MacNeil, Mary G. Reynolds, Inger K. Damon, Risks associated with vaccinia virus in the laboratory, Virology, 2009, 385, 1, 1

    CrossRef

  46. 46
    Richard B. Kennedy, Inna Ovsyannikova, Gregory A. Poland, Smallpox vaccines for biodefense, Vaccine, 2009, 27, D73

    CrossRef

  47. 47
    Richard B Kennedy, Inna G Ovsyannikova, Robert M Jacobson, Gregory A Poland, The immunology of smallpox vaccines, Current Opinion in Immunology, 2009, 21, 3, 314

    CrossRef

  48. 48
    Juan E. Moyron-Quiroz, Megan M. McCausland, Robin Kageyama, Alessandro Sette, Shane Crotty, The smallpox vaccine induces an early neutralizing IgM response, Vaccine, 2009, 28, 1, 140

    CrossRef

  49. 49
    Giliane S. Trindade, Maria I. C. Guedes, Betânia P. Drumond, Bruno E. F. Mota, Jônatas S. Abrahão, Zélia I. P. Lobato, Juliana A. S. Gomes, Rodrigo Corrêa-Oliveira, Maurício L. Nogueira, Erna G. Kroon, Flávio G. da Fonseca, Zoonotic Vaccinia Virus: Clinical and Immunological Characteristics in a Naturally Infected Patient, Clinical Infectious Diseases, 2009, 48, 3, e37

    CrossRef

  50. 50
    C. I. Yu, M. Gallegos, F. Marches, G. Zurawski, O. Ramilo, A. Garcia-Sastre, J. Banchereau, A. K. Palucka, Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines, Blood, 2008, 112, 9, 3671

    CrossRef

  51. 51
    Dennis D. Taub, William B. Ershler, Mark Janowski, Andrew Artz, Michael L. Key, Julie McKelvey, Denis Muller, Bernard Moss, Luigi Ferrucci, Patricia L. Duffey, Dan L. Longo, Immunity from Smallpox Vaccine Persists for Decades: A Longitudinal Study, The American Journal of Medicine, 2008, 121, 12, 1058

    CrossRef

  52. 52
    Blaise Dondji, Eszter Deak, Karen Goldsmith-Pestana, Eva Perez-Jimenez, Mariano Esteban, Sachiko Miyake, Takashi Yamamura, Diane McMahon-Pratt, Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania, European Journal of Immunology, 2008, 38, 3
  53. 53
    Xiaocong Yu, Tshidi Tsibane, Patricia A. McGraw, Frances S. House, Christopher J. Keefer, Mark D. Hicar, Terrence M. Tumpey, Claudia Pappas, Lucy A. Perrone, Osvaldo Martinez, James Stevens, Ian A. Wilson, Patricia V. Aguilar, Eric L. Altschuler, Christopher F. Basler, James E. Crowe Jr, Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors, Nature, 2008, 455, 7212, 532

    CrossRef

  54. 54
    Andrew W. Artenstein, New generation smallpox vaccines: a review of preclinical and clinical data, Reviews in Medical Virology, 2008, 18, 4
  55. 55
    Alessandro Sette, Magdalini Moutaftsi, Juan Moyron-Quiroz, Megan M. McCausland, D. Huw Davies, Robert J. Johnston, Bjoern Peters, Mohammed Rafii-El-Idrissi Benhnia, Julia Hoffmann, Hua-Poo Su, Kavita Singh, David N. Garboczi, Steven Head, Howard Grey, Philip L. Felgner, Shane Crotty, Selective CD4+ T Cell Help for Antibody Responses to a Large Viral Pathogen: Deterministic Linkage of Specificities, Immunity, 2008, 28, 6, 847

    CrossRef

  56. 56
    Tomáš Hanke, STEP trial and HIV-1 vaccines inducing T-cell responses, Expert Review of Vaccines, 2008, 7, 3, 303

    CrossRef

  57. 57
    R.-P. Sekaly, The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?, Journal of Experimental Medicine, 2008, 205, 1, 7

    CrossRef

  58. 58
    Niroshan Ramachandran, Karen S. Anderson, Jacob V. Raphael, Eugenie Hainsworth, Sahar Sibani, Wagner R. Montor, Marcin Pacek, Jessica Wong, Mariam Eljanne, Martin G. Sanda, Yanhui Hu, Tanya Logvinenko, Joshua LaBaer, Tracking humoral responses using self assembling protein microarrays, PROTEOMICS - Clinical Applications, 2008, 2, 10-11
  59. 59
    Stanley A. Plotkin, Vaccines: Correlates of Vaccine-Induced Immunity, Clinical Infectious Diseases, 2008, 47, 3, 401

    CrossRef

  60. 60
    Scott N. Mueller, Barry T. Rouse, Clinical Immunology, 2008,

    CrossRef

  61. 61
    David C Tscharke, Adaptive immunity to vaccinia virus: revisiting an old friend, Future Virology, 2007, 2, 2, 163

    CrossRef

  62. 62
    Eric L. Simpson, Michelle Hercher, Erika K. Hammarlund, Matthew W. Lewis, Mark K. Slifka, Jon M. Hanifin, Cutaneous responses to vaccinia in individuals with previous smallpox vaccination, Journal of the American Academy of Dermatology, 2007, 57, 3, 442

    CrossRef

  63. 63
    Ian J. Amanna, Nichole E. Carlson, Mark K. Slifka, Duration of Humoral Immunity to Common Viral and Vaccine Antigens, New England Journal of Medicine, 2007, 357, 19, 1903

    CrossRef

  64. 64
    Verena Schlaphoff, Christoph S. Klade, Bernd Jilma, Sandra B. Jelovcan, Markus Cornberg, Erich Tauber, Michael P. Manns, Heiner Wedemeyer, Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients, Vaccine, 2007, 25, 37-38, 6793

    CrossRef

  65. 65
    Matthew A. Fischer, Christopher C. Norbury, Initiation of primary anti-vaccinia virus immunity in vivo, Immunologic Research, 2007, 37, 2, 113

    CrossRef

  66. 66
    Rafi Ahmed, Michael B A Oldstone, Peter Palese, Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic, Nature Immunology, 2007, 8, 11, 1188

    CrossRef

  67. 67
    Xiaoyan Zhan, Julia L. Hurwitz, Sateesh Krishnamurthy, Toru Takimoto, Kelli Boyd, Ruth A. Scroggs, Sherri Surman, Allen Portner, Karen S. Slobod, Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B, Vaccine, 2007, 25, 52, 8782

    CrossRef

  68. 68
    Ian J. Amanna, Mark K. Slifka, Quantitation of rare memory B cell populations by two independent and complementary approaches, Journal of Immunological Methods, 2006, 317, 1-2, 175

    CrossRef

  69. 69
    Simon Urschel, Lori J. West, Developmental Immunity: From Birth to Adult,
  70. 70
    Catharine M. Bosio, Megan MacLeod, Philippa Marrack, Ross M. Kedl, Utility of Mouse Models in Vaccine Design and Development,